United States · FDA National Drug Code directory
ABREVA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0135-0300_1b529b4c-e36d-5070-e063-6294a90ac5c8
- Product NDC
- 0135-0300
- Form
- CREAM
- Composition / generic term
- docosanol
- Labeler
- Haleon US Holdings LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220325
- Source listing expiry
- 20261231
Source-listed ingredients
- DOCOSANOL — 100 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TUBE in 1 PACKAGE (0135-0300-01) / 2 g in 1 TUBE · 0135-0300-01
- 2 TUBE in 1 PACKAGE (0135-0300-02) / 2 g in 1 TUBE · 0135-0300-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →